17 November 2017Americas

Texas universities sue J&J subsidiary over biodegradable fibres

A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

More on this story

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

More on this story

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

More features

President Trump 2.0: Five major areas to watch

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug